Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
D000372:Agglutination Tests; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D002459:Cell Fusion; D002875:Chromosomes; D003208:Concanavalin A / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005347:Fibroblasts; D006649:Histocompatibility Antigens; D006822:Hybrid Cells; D007519:Isoantigens; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D008855:Microscopy, Electron, Scanning; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D007519:Isoantigens; D003208:Concanavalin A